Theratechnologies Inc.

Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements Apr 09, 2025 Download FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy Total Revenue $19 million, representing +17% growth year over year FDA Approves […]

Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company Apr 11, 2025   Download MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, wishes to […]

Theratechnologies Provides Update on Sale Process

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Provides Update on Sale Process Apr 15, 2025   Download MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that following careful consideration of the current circumstances, including the publicly announced proposal from Future […]

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV May 02, 2025 Download VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, […]

Theratechnologies Reports on its Annual Meeting of Shareholders

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Reports on its Annual Meeting of Shareholders May 29, 2025 Download MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today in a […]

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak Jul 02, 2025 Download Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per share Upfront and total potential cash consideration […]

Theratechnologies to Announce Second Quarter 2025 Financial Results

Theratechnologies Reports Financial Results for the Second Quarter 2025

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Reports Financial Results for the Second Quarter 2025 Jul 09, 2025 Download Q2 2025 total revenue of $17.7 million, and $36.8 million for the first six months of Fiscal 2025 Positive Adjusted EBITDA1 for the fifth straight quarter Subsequent to quarter end, Theratechnologies entered into a definitive […]

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak Aug 18, 2025 Download Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a […]

Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak

Youtube X-twitter Linkedin-in News Email Alerts RSS Feeds Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak Sep 02, 2025 Download Your vote is important regardless of the number of Shares you own. Board unanimously recommends shareholders vote “FOR” the Arrangement. Shareholders […]

Report on Modern Slavery